HR-VILAGE-3K3M: A Human Respiratory Viral Immunization Longitudinal Gene Expression Dataset for Systems Immunity
Xuejun Sun, Yiran Song, Xiaochen Zhou, Ruilie Cai, Yu ZhangXinyi Li, Rui Peng, Jialiu Xie, Yuanyuan Yan, Muyao TangPrem Lakshmanane, Baiming Zou, James S. Hagood, Raymond J. Pickles, Didong Li, Fei Zou, Xiaojing ZhengUniversity of North Carolina at Chapel Hill [email protected], [email protected] · 2025
Read HR-VILAGE-3K3M: A Human Respiratory Viral Immunization Longitudinal Gene Expression Dataset for Systems Immunity by Xuejun Sun, Yiran Song, Xiaochen Zhou, Ruilie Cai, Yu ZhangXinyi Li, Rui Peng, Jialiu Xie, Yuanyuan Yan, Muyao TangPrem Lakshmanane, Baiming Zou, James S. Hagood, Raymond J. Pickles, Didong Li, Fei Zou, Xiaojing ZhengUniversity of North Carolina at Chapel Hill [email protected], [email protected] (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-14725.txt.
Introduction
Xuejun Sun and co-authors build a large gene expression data set on respiratory virus immunization in a 2025 paper. Respiratory infections burden health worldwide, yet the cell level immune paths to protection remain unclear. Infection studies lack before exposure baselines, while vaccine and challenge trials give timed samples. Those data were scattered and processed unevenly, blocking joint analysis.
Their repository harmonizes bulk and single cell profiles from 3178 subjects across 66 studies. It spans vaccination, deliberate infection, and mixed exposures, with blood and nasal samples from public archives. Subject data and outcomes were standardized with strict quality control. Benchmark analyses show its use for finding markers and immune mechanisms. Readers gain an AI ready resource for vaccine research.
Catalog record
| CREATOR | Xuejun Sun, Yiran Song, Xiaochen Zhou, Ruilie Cai, Yu ZhangXinyi Li, Rui Peng, Jialiu Xie, Yuanyuan Yan, Muyao TangPrem Lakshmanane, Baiming Zou, James S. Hagood, Raymond J. Pickles, Didong Li, Fei Zou, Xiaojing ZhengUniversity of North Carolina at Chapel Hill [email protected], [email protected] |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2505-14725
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
HR-VILAGE-3K3M: A Human Respiratory Viral Immunization Longitudinal Gene Expression Dataset for Systems Immunity Xuejun Sun, Yiran Song, Xiaochen Zhou, Ruilie Cai, Yu ZhangXinyi Li, Rui Peng, Jialiu Xie, Yuanyuan Yan, Muyao TangPrem Lakshmanane, Baiming Zou, James S. Hagood, Raymond J. Pickles, Didong Li, Fei Zou, Xiaojing ZhengUniversity of North Carolina at Chapel Hill [email protected], [email protected], [email protected]@unc.edu, [email protected], [email protected]@live.unc.edu, [email protected], [email protected]@med.unc.edu, [email protected],[email protected], [email protected],[email protected], [email protected], [email protected] University of South Carolina [email protected] Abstract Respiratory viral infections pose a global health burden, yet the cellular immune responses driving protection or pathology remain unclear. Natural infection cohorts often lack pre-exposure baseline data and structured temporal sampling. In contrast, inoculation and vaccination trials generate insightful longitudinal transcriptomic data. However, the scattering of these datasets across platforms and repositories, along with inconsistent metadata and preprocessing procedure, hinders AI-driven discovery. To address these challenges, we developed the Human Respiratory Viral Immunization LongitudinAl Gene Expression (HR-VILAGE-3K3M) repository: an AI-ready, rigorously curated dataset that integrates 14,136 RNA sequencing (RNA-seq) profiles from 3,178 subjects across 66 studies encompassing over 2.56 million cells. Spanning vaccination, inoculation, and mixed exposures, the dataset includes microarray, bulk RNA-seq, and single-cell RNA-seq from whole blood, human peripheral blood mononuclear cells (PBMCs), and nasal swabs, sourced from Gene Expression Omnibus, ImmPort, and ArrayExpress. We harmonized subject-level metadata, standardized outcome measures (e.g., responder classifications), applied unified preprocessing pipelines with rigorous quality control, and aligned all data to official gene symbols. To demonstrate the utility of HR-VILAGE-3K3M, we performed predictive modeling of vaccine responders and evaluated batch-effect correction methods across platforms. Beyond these initial demonstrations, it supports diverse systems immunology applications, including the discovery of early biomarkers, disease mechanisms, the development and benchmarking of feature selection and transfer learning algorithms. Its scale and heterogeneity also make it ideal for pretraining foundation models of the human immune response and for advancing multimodal learning frameworks that integrate bulk and single-cell RNA-seq data with clinical and antibody measurements over time. As the largest longitudinal transcriptomic resource for human respiratory viral immunization, it provides a standardized, accessible platform for reproducible and scalable AI-driven research, accelerating systems immunology and vaccine development against emerging viral threats. 1 Introduction Acute respiratory viral infections, such as those caused by influenza, respiratory syncytial virus (RSV), human rhinovirus (HRV) and SARS-CoV-2, represent a significant global health burden [ 1 , 2 , 3 , 4 ] . Vaccination remains the most effective strategy for preventing infection and reducing transmission [ 5 , 6 , 7 ] . Both humoral (antibody) and cellular immunity are essential for controlling viral infections . The diversity and specificity of antibody responses are influenced by the complex interactions among various immune cells. There is a critical need to deeply understand the human cellular immune responses to antigens over time. However, natural infection studies frequently lack pre-infection baseline data and cannot control infection timing. Conversely, human inoculation and vaccine studies offer unique opportunities to observe immune cell responses within a structured timeline. Studies involving blood leukocytes and nasal swabs have demonstrated that both systemic and local cellular immunity are crucial in defending against respiratory viral infections and diseases [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 ] . Extensive transcriptomic data from human inoculation and vaccination studies have been deposited in publicly accessible databases, such as GEO (Gene Expression Omnibus), ImmPort Shared Data, and the ArrayExpress Collection at EMBL-EBI [ 16 , 17 , 18 ] . However, the analytical power of a single cohort is limited and likely to yield inconsistent results, highlighting the need for integrated data analysis across multiple studies. Furthermore, integrating these data is invaluable for promoting reusable research and for developing advanced Artificial Intelligence (AI) and machine learning (ML) models. By leveraging the structured and detailed information from these studies, researchers can build reliable and robust transfer learning models for enhancing our understanding of infectious diseases and outcome predictions, and improving the development of personalized treatments and new vaccines. The integration of AI/ML in this domain holds the potential to revolutionize how we approach and manage infectious diseases, leading to better health outcomes ultimately. Integrating data across studies presents several challenges. First, while public repositories host extensive gene expression datasets, there remains a significant gap between data availability and readiness for analysis. For instance, GEO provides data at various levels of processing, including raw, partially processed, and fully normalized data. These datasets are often generated through distinct study-specific pipelines by different research groups, leading to apparent batch effects. Second, metadata, including information on outcomes (e.g., infection status, symptoms, and antibody responses), is often fragmented in the supplementary files of the original papers or other places rather than where the gene expression data are deposited. For example, expression profiles are often available in GEO, while phenotypic data are stored in ImmPort, with subject-level antibody titers frequently missing. More problematic, the metadata use sample IDs that differ from those used by the expression data in several instances, making data merging impossible and requiring significant human effort to communicate with the principal investigators of those studies [ 19 , 20 , 21 ] . Third, data have been profiled using various platforms (microarray, bulk RNA sequencing (RNA-Seq), and Single-cell RNA sequencing (scRNA-seq)) and are represented using inconsistent gene symbols due to different probe designs and methods of gene identification, such as alias gene symbols found in literature instead of official nomenclature [ 22 ] . Lastly, a rigorous data preprocessing evaluation is lacking. Some datasets show abnormal sample correlations, including negative values indicative of technical artifacts, or irregular count distributions such as expression values restricted to a few discrete levels—likely stemming from improper preprocessing of raw data. In addition, duplicate samples originating from the same subjects but deposited under different studies are occasionally present, necessitating careful detection and removal to ensure consistency and integrity of the integrated dataset. To overcome these barriers, we created the Human Respiratory Viral Immunization Longitudinal Gene Expression (HR-VILAGE-3K3M) data repository, a curated benchmark dataset encompassing over 3,000 participants from 66 studies, including vaccination, inoculation, and post-vaccination infection studies. We undertook extensive efforts to align metadata and gene expression profiles from disparate sources, ensuring a unified and analyzable structure across all datasets. This involved resolving inconsistencies in sample identifiers, correcting formatting errors (e.g., Excel-induced gene symbol corruption), and harmonizing gene annotations to official HUGO Gene Nomenclature Committee (HGNC) symbols [ 23 ] . In many cases, essential subject-level antibody data were missing from public repositories and had to be obtained directly from study authors through targeted email outreach. We also standardized heterogeneous outcome definitions across studies to enable meaningful comparisons. To ensure data integrity, we conducted rigorous quality control by identifying and excluding duplicated samples, reprocessing data from raw files when available, and filtering out datasets exhibiting abnormal or unreliable sample-level correlations. These curation and preprocessing efforts were critical in transforming raw, fragmented datasets into harmonized, ready-to-use gene expression matrices, allowing researchers to bypass the otherwise time-consuming and technically challenging steps of data discovery, cleaning, and integration. HR-VILAGE-3K3M supports a wide range of applications, such as the discovery of early biomarkers, identification of disease-driving or causal genes, and understanding the temporal dynamics of immune responses to various pathogens through integrative data